IL-15, IL-21 (oral delivery)
BNZ-3 is a modified, stapled BNZ-2 peptide that retains the same binding motifs to inhibit IL-15 and IL-21 for local delivery to the GI tract. BNZ-3 is stable in stomach and intestinal fluid.
BNZ-3 is a modified, stapled BNZ-2 peptide that retains the same binding motifs to inhibit IL-15 and IL-21 for local delivery to the GI tract. BNZ-3 is stable in stomach and intestinal fluid.